Frankfurt - Delayed Quote EUR

Ipsen S.A. (I7G.F)

103.80
+3.90
+(3.90%)
At close: May 13 at 8:18:33 AM GMT+2
All All Favorites Text Statistics Technicals Fibonacci Markings Lines
Loading Chart for I7G.F

Recent News: I7G.F

View More
Ipsen - April 2025 - Monthly information relative to the total number of voting rights and shares composing the share capital

Ipsen - April 2025 - Monthly information relative to the total number of voting rights and shares composing the share capital
GlobeNewswire yesterday
Late-breaking exploratory data highlights the impact of IQIRVO® (elafibranor) on fatigue and provides mechanistic insights into anti-inflammatory and symptom-related effects in patients with primary biliary cholangitis

Late-breaking exploratory data highlights the impact of IQIRVO® (elafibranor) on fatigue and provides mechanistic insights into anti-inflammatory and symptom-related effects in patients with primary biliary cholangitis
GlobeNewswire 6 days ago
Ipsen appoints Laura Réveillon as EVP, Strategy & Transformation

Ipsen appoints Laura Réveillon as EVP, Strategy & Transformation
GlobeNewswire 7 days ago
Ipsen S.A. - Formalities for making available and consulting preparatory documents to the 2025 Annual General Meeting

Ipsen S.A. - Formalities for making available and consulting preparatory documents to the 2025 Annual General Meeting
GlobeNewswire 13 days ago
Late-breaking elafibranor primary sclerosing cholangitis (PSC) data demonstrates favorable safety profile and significant efficacy in second potential rare liver disease indication

Late-breaking elafibranor primary sclerosing cholangitis (PSC) data demonstrates favorable safety profile and significant efficacy in second potential rare liver disease indication
GlobeNewswire 19 days ago
Ipsen delivers strong sales in the first quarter 2025 and confirms its full-year guidance

Ipsen delivers strong sales in the first quarter 2025 and confirms its full-year guidance
GlobeNewswire 27 days ago
Ipsen - March 2025 - Monthly information relative to the total number of voting rights and shares composing the share capital

Ipsen - March 2025 - Monthly information relative to the total number of voting rights and shares composing the share capital
GlobeNewswire 29 days ago
Ipsen publishes its 2024 Universal Registration Document

Ipsen publishes its 2024 Universal Registration Document
GlobeNewswire last month
Ipsen announces issuance of €500 million inaugural Rated Public Bond

Ipsen announces issuance of €500 million inaugural Rated Public Bond
GlobeNewswire last month
Ipsen appoints Olivia Brown as Executive Vice-President, Global Head of Neurotoxins

Ipsen appoints Olivia Brown as Executive Vice-President, Global Head of Neurotoxins
GlobeNewswire 2 months ago
Ipsen - February 2025 - Monthly information relative to the total number of voting rights and shares composing the share capital

Ipsen - February 2025 - Monthly information relative to the total number of voting rights and shares composing the share capital
GlobeNewswire 2 months ago
View More